Company Profile

Verachem LLC
Profile last edited on: 6/19/17      CAGE: 4ERK4      UEI: MJP3SNX9RCN6

Business Identifier: scientific software for computer-aided drug discovery and molecular design
Year Founded
2000
First Award
2000
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

12850 Middlebrook Road Suite 205
Germantown, MD 20874
   (240) 686-0565
   vc@verachem.com
   www.verachem.com
Location: Single
Congr. District: 06
County: Montgomery

Public Profile

VeraChem LLC, spun out of the University of Maryland Biotechnology Institute (UMBI), has created scientific software to provide expert users with tools for computer-aided drug discovery and molecular design. The firm develops and markets innovative software for the analysis and design of molecules to the biotech and pharmaceutical industries. VeraChem's software capabilities include protein-ligand and host-guest binding affinity prediction, fast calculation of accurate partial atomic charges for drug-like compounds, computation of energies and forces with commonly used empirical force fields, automatic generation of alternate resonance forms of drug-like compounds, conformational search with the powerful Tork distort-minimize algorithm, and automatic detection of topological and 3D molecular symmetries.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Michael J Potter -- Chief Executive Officer

  Hillary S R Gilson -- Founder

  Michael K Gilson -- Scientific Advisor

  Simon Webb -- CSO

Company News

There are no news available.